NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
An Academy Award winning director is seeking Hep C patients for a web documentary film about Hep C and the challenges related to living with the disease.
The American Medical Association launched a website for consumers to tell their stories of how rising prices are affecting their health and their pocketbooks.
The Centers for Medicare and Medicaid Services (CMS) made the final decision to cover screening for hepatitis B infection at no cost to individuals entitled to benefits under Medicare Part A or enrolled in Medicare Part B.
The letter of support urges the House and Senate Appropriations Committees to fund the Division of Viral Hepatitis at a level of $62.8 million in FY2017.
The NYS Attorney General’s office requests that all patients, their doctors, or their representatives make a call to Health Care Bureau’s toll-free Helpline or fill out a complaint form if they feel they have been wrongly denied coverage for their Hep C treatment medications.
Mary T. Basset, NYC Health Commissioner, wrote a letter to CMS in support of Medicare coverage of Hepatitis B screening.
Join the #FundHep social media campaign in an effort to advocate for more Federal funds for hepatitis in FY2017!
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
To determine the impact of the NYS Hepatitis C Testing Law, the NYSDOH drew from multiple data sources that assessed testing levels in New York before and after the law went into effect.
